News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,395 Results
Type
Article (5015)
Company Profile (17)
Press Release (220363)
Section
Business (82202)
Career Advice (461)
Deals (15042)
Drug Delivery (8)
Drug Development (19065)
Employer Resources (30)
FDA (3676)
Job Trends (3901)
News (120107)
Policy (7502)
Tag
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14777)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3695)
Artificial intelligence (42)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (454)
Cardiovascular disease (24)
Career advice (393)
Career pathing (3)
CAR-T (32)
Cell therapy (106)
Cervical cancer (2)
Clinical research (16040)
Collaboration (172)
Compensation (171)
Complete response letters (2)
COVID-19 (301)
CRISPR (8)
C-suite (110)
Cystic fibrosis (16)
Data (526)
Depression (7)
Diabetes (43)
Diagnostics (2042)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40909)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37830)
Executive appointments (315)
FDA (3939)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (16)
Generative AI (2)
Gene therapy (53)
GLP-1 (109)
Government (412)
Guidances (20)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7824)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (32)
Management (10)
Manufacturing (50)
MASH (29)
Medical device (3861)
Medtech (3862)
Mergers & acquisitions (7425)
Metabolic disorders (125)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (345)
NextGen: Class of 2025 (1674)
Non-profit (727)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (14)
Pancreatic cancer (14)
Parkinson's disease (28)
Partnered (4)
Patents (21)
Patient recruitment (32)
Peanut (5)
People (24610)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4783)
Phase II (6964)
Phase III (5551)
Pipeline (575)
Policy (9)
Postmarket research (625)
Preclinical (1876)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1874)
Recruiting (8)
Regulatory (5126)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (4)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1009)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
Vaccines (36)
Venture capitalists (2)
Weight loss (22)
Women's health (1)
Date
Today (67)
Last 7 days (227)
Last 30 days (712)
Last 365 days (9960)
2025 (3209)
2024 (11027)
2023 (13194)
2022 (18659)
2021 (19679)
2020 (18238)
2019 (13205)
2018 (10206)
2017 (10002)
2016 (9159)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11461)
Australia (1611)
California (1991)
Canada (714)
China (73)
Colorado (84)
Connecticut (97)
Delaware (30)
Europe (24539)
Florida (286)
Georgia (34)
Idaho (23)
Illinois (116)
India (7)
Indiana (64)
Iowa (2)
Japan (74)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1592)
Michigan (86)
Minnesota (141)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (576)
New Mexico (5)
New York (480)
North Carolina (332)
North Dakota (3)
Northern California (950)
Ohio (60)
Oklahoma (5)
Oregon (4)
Pennsylvania (352)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (717)
Tennessee (40)
Texas (230)
United States (7198)
Utah (61)
Virginia (46)
Washington D.C. (9)
Washington State (176)
West Virginia (2)
Wisconsin (25)
225,395 Results for "verseon corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Verseon Acquires Edammo
Verseon International Corporation, the company leading a technology-driven transformation of the pharmaceutical industry, announces that it has acquired Edammo, Inc.
October 18, 2022
·
2 min read
Biotech Bay
Verseon Gains European Patent Protection for Potential Sight and Life-Saving Treatments
Verseon is pleased to announce that the European Patent Office has granted intellectual property protection covering novel chemical matter developed by Verseon that includes the company’s plasma kallikrein inhibitors (PKIs).
September 7, 2022
·
3 min read
Deals
Verseon Acquires Edammo to Deepen Drug Discovery Approach
Verseon has acquired Edammo, an artificial intelligence-focused company, to deepen its own AI-based drug discovery platform. Financial terms were not disclosed.
October 14, 2022
·
4 min read
·
Mark Terry
Drug Development
Verseon’s Atomic-Level Drug Design is Changing the Paradigm of Drug Discovery
What sets Verseon apart is its use of molecular physics modeling to enable the atomic-level engineering of new molecules. The company has 14 small molecule drugs in development.
May 2, 2022
·
5 min read
·
Gail Dutton
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Press Releases
Quantum BioPharma Corporate Update
April 21, 2025
·
4 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Press Releases
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller
April 17, 2025
·
7 min read
Press Releases
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
March 26, 2025
·
17 min read
Press Releases
Lobe Sciences Provides Corporate Update
April 7, 2025
·
8 min read
1 of 22,540
Next
